The adverse influence of spina bifida occulta on the medical treatment outcome of primary monosymptomatic nocturnal enuresis


Submitted: January 23, 2015
Accepted: January 23, 2015
Published: December 30, 2014
Abstract Views: 2204
PDF: 1133
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Basri Cakiroglu Hisar Intercontinental Hospital, Department of Urology, Umraniye, Istanbul, Turkey.
  • Tuncay Tas Taksim Training and Research Hospital, Department of Urology, Taksim, Istanbul, Turkey.
  • Seyit Erkan Eyyupoglu Amasya Training and Research Hospital, Department of Urology, Amasya, Turkey.
  • Aydın Ismet Hazar Taksim Training and Research Hospital, Department of Urology, Taksim, Istanbul, Turkey.
  • Mustafa Bahadır Can Balcı Taksim Training and Research Hospital, Department of Urology, Taksim, Istanbul, Turkey.
  • Yunus Nas Hisar Intercontinental Hospital, Department of Pediatry, Umraniye, Istanbul, Turkey.
  • Fazli Yilmazer Hisar Intercontinental Hospital, Department of Pediatry, Umraniye, Istanbul, Turkey.
  • Suleyman Hilmi Aksoy Hisar Intercontinental Hospital, Department of Radiology, Umraniye, Istanbul, Turkey.
Objective: Previous reports have suggested that the incidence of spina bifida occulta (SBO) in patients with primary monosymptomatic nocturnal enuresis (PMNE) is higher than the general population. The purpose of this study was to investigate the effect of spina bifida occulta on the medical treatment outcome of PMNE. Material and Methods: Between January 2008 and December 2011, a total of 223 children (151 boys and 72 girls, aged 6-16 years; mean age: 10.1 ± 3.04 years) with PMNE were reviewed retrospectively. All of the children underwent physical examination, urine analysis, urinary tract ultrasonography and kidney ureter bladder (KUB) scout film. All patients were initially treated with a timed voiding program and were given desmopressin acetate when necessary. Results: Spina bifida occulta was detected in 75 children (33.6%). Spina bifida occulta affected L4 in 2 children, L5 in 6 children, L4-L5 in 3 children, S1 in 52 children, S2 in 7 children and S1-S2 in 2 children. Treatment was successful in 79% of the children without SBO, and in only 48% of the children with SBO. Medical treatment success rates differed significantly between the study groups. Conclusion: The presence of spina bifida occulta significantly affects the response to medical treatment in patients with PMNE. Thus, verifying spina bifida occulta status in PMNE can facilitate prognostic predictions about the response to medical treatment.

Cakiroglu, B., Tas, T., Eyyupoglu, S. E., Hazar, A. I., Can Balcı, M. B., Nas, Y., Yilmazer, F., & Aksoy, S. H. (2014). The adverse influence of spina bifida occulta on the medical treatment outcome of primary monosymptomatic nocturnal enuresis. Archivio Italiano Di Urologia E Andrologia, 86(4), 270–273. https://doi.org/10.4081/aiua.2014.4.270

Downloads

Download data is not yet available.

Citations